46th week of 2017 patent applcation highlights part 9 |
Patent application number | Title | Published |
20170326199 | USE OF CASPASE-2 INHIBITORS TO TREAT AND PREVENT THE METABOLIC SYNDROME | 2017-11-16 |
20170326200 | Method of Treating Prader-Willi Syndrome | 2017-11-16 |
20170326201 | NOVEL FAT ACCUMULATION INHIBITORY PEPTIDE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OBESITY CONTAINING THE SAME | 2017-11-16 |
20170326202 | PIRIN POLYPEPTIDE AND IMMUNE MODULATION | 2017-11-16 |
20170326203 | Methods of Treating Autoimmune Diseases | 2017-11-16 |
20170326204 | COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE | 2017-11-16 |
20170326205 | METHODS AND COMPOSITIONS FOR TREATMENT OF METASTATIC AND REFRACTORY CANCERS AND TUMORS | 2017-11-16 |
20170326206 | DOSAGE REGIMEN FOR PEGYLATED INTERFERON | 2017-11-16 |
20170326207 | Thymosin Beta 4 Promotes Wound Repair | 2017-11-16 |
20170326208 | TREATMENT OF DISEASES ASSSOCIATED WITH FAT ACCUMULATION | 2017-11-16 |
20170326209 | BEVERAGE, AND METHOD OF PRODUCING THE SAME | 2017-11-16 |
20170326210 | SIALYLATED GLYCOPROTEIN COMPOSITIONS AND USES THEREOF | 2017-11-16 |
20170326211 | CELL THERAPY FOR THE TREATMENT OF NEURODEGENERATION | 2017-11-16 |
20170326212 | SYNTHETIC METHYLMALONYL-COA MUTASE TRANSGENE FOR THE TREATMENT OF MUT CLASS METHYLMALONIC ACIDEMIA (MMA) | 2017-11-16 |
20170326213 | Protein-Coupled Red Blood Cell Compositions and Methods of Their Use | 2017-11-16 |
20170326214 | CD4 T cells provide antibody access to immunoprivileged tissue | 2017-11-16 |
20170326215 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS | 2017-11-16 |
20170326216 | Immunotherapy against melanoma and other cancers | 2017-11-16 |
20170326217 | NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS | 2017-11-16 |
20170326218 | PEPTIDE MIXTURE | 2017-11-16 |
20170326219 | Vaccine for Falciparum Malaria | 2017-11-16 |
20170326220 | MENINGITIS B VACCINE | 2017-11-16 |
20170326221 | Detoxification method for lipopolysaccharide (LPS) or lipid A of Gram-negative bacteria | 2017-11-16 |
20170326222 | NON-LIPIDATED VARIANTS OF NEISSERIA MENINGITIDIS ORF2086 ANTIGENS | 2017-11-16 |
20170326223 | NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN E; pE) | 2017-11-16 |
20170326224 | HUMAN PAPILLOMA VIRUS CONSTRUCTS | 2017-11-16 |
20170326225 | EBOLAVIRUS AND MARBURGVIRUS VACCINES | 2017-11-16 |
20170326226 | COMPOSITION COMPRISING ANTIGENS AND A MUCOSAL ADJUVANT AND A METHOD FOR USING | 2017-11-16 |
20170326227 | INFLUENZA VIRUS REASSORTMENT | 2017-11-16 |
20170326228 | RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE | 2017-11-16 |
20170326229 | SWARM IMMUNIZATION WITH 54 ENVELOPES FROM CH505 | 2017-11-16 |
20170326230 | STABLE LIQUID VACCINIA VIRUS FORMULATIONS | 2017-11-16 |
20170326231 | EPITOPE OF HEPATITIS B VIRUS SURFACE ANTIGEN AND BINDING MOLECULE SPECIFICALLY BINDING TO SAME FOR NEUTRALIZING HAPATITIS B VIRUS | 2017-11-16 |
20170326232 | INTRATUMORAL ADMINISTRATION OF PARTICLES CONTAINING A TOLL-LIKE RECEPTOR 9 AGONIST AND A TUMOR ANTIGEN FOR TREATING CANCER | 2017-11-16 |
20170326233 | CONJUGATES INCLUDING AN ANTIBODY MOIETY, A POLYPEPTIDE THAT TRAVERSES THE BLOOD-BRAIN BARRIER, AND A CYTOTOXIN | 2017-11-16 |
20170326234 | COMBINATION THERAPIES | 2017-11-16 |
20170326235 | COMBINATION TUMOR TREATMENT WITH DRUG-LOADED, BISPECIFIC LIGAND-TARGETED MINICELLS AND INTERFERON-GAMMA | 2017-11-16 |
20170326236 | ION IMPLANTATION OF NEUTRON CAPTURE ELEMENTS INTO NANODIAMOND PARTICLES TO FORM COMPOSITION FOR NEUTRON CAPTURE THERAPY USAGE | 2017-11-16 |
20170326237 | COSMETIC AND PHARMACEUTICAL AGENTS FOR TREATING WOUNDS AND/OR HEMORRHAGING OF THE SKIN, MUCOUS MEMBRANES OR THE GUM, IN PARTICULAR, FOR EXAMPLE, SUPERFICIAL CRACKS (RHAGADES) OR PERIODONTITIS | 2017-11-16 |
20170326238 | CROSSLINKING OF CD22 BY EPRATUZUMAB TRIGGERS BCR SIGNALING AND CASPASE-DEPENDENT APOPTOSIS IN HEMATOPOIETIC CANCER CELLS | 2017-11-16 |
20170326239 | ARTIFICIAL BACTERIOPHAGE BASED ON CARBON NANOSTRUCTURES FOR SUPPLYING MEDICAMENTS | 2017-11-16 |
20170326240 | STABILIZED EFINACONAZOLE COMPOSITIONS | 2017-11-16 |
20170326241 | WOUND HEALING USING TOPICAL SYSTEMS AND METHODS | 2017-11-16 |
20170326242 | FILMOGENIC COMPOSITIONS FOR TOPICAL ANAESTHETIC BIOADHESIVES - TABS, FOR CONTROLLED RELEASE OF ACTIVE PRINCIPLES AND TOPICAL ANAESTHETIC BIOADHESIVES | 2017-11-16 |
20170326243 | METHODS AND SYSTEMS FOR TREATING OR PREVENTING CANCER | 2017-11-16 |
20170326244 | BIOTIN COMPLEXES FOR TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE | 2017-11-16 |
20170326245 | Methods and Compositions Related To Annexin 1-Binding Compounds | 2017-11-16 |
20170326246 | CONJUGATED MOLECULES COMPRISING A PEPTIDE DERIVED FROM THE CD4 RECEPTOR COUPLED TO AN ANIONIC POLYPEPTIDE FOR THE TREATMENT OF AIDS | 2017-11-16 |
20170326247 | ANTIBODY-DRUG CONJUGATES OF TUBULYSIN ANALOGS WITH ENHANCED STABILITY | 2017-11-16 |
20170326248 | ANTI-CD22 ANTIBODIES AND IMMUNOCONJUGATES | 2017-11-16 |
20170326249 | ANTIBODY-DRUG CONJUGATE OF AN ANTI-GLYPICAN-3 ANTIBODY AND A TUBULYSIN ANALOG, PREPARATION AND USES | 2017-11-16 |
20170326250 | CELL PROLIFERATION INHIBITORS AND CONJUGATES THEREOF | 2017-11-16 |
20170326251 | METHOD OF SYNTHESIZING ANTIBODY DRUG CONJUGATES USING AFFINITY RESINS | 2017-11-16 |
20170326252 | Nanoparticles for Delivery of Agents to Glioblastoma Tumors | 2017-11-16 |
20170326253 | PH-SENSITIVE PEPTIDES AND THEIR NANOPARTICLES FOR DRUG DELIVERY | 2017-11-16 |
20170326254 | Efficient delivery of therapeutic molecules in vitro and in vivo | 2017-11-16 |
20170326255 | SUCROSE ESTER BASED CATIONIC GENE VECTOR AND PREPARATION METHOD THEREOF | 2017-11-16 |
20170326256 | RECOMBINANT PROMOTERS AND VECTORS FOR PROTEIN EXPRESSION IN LIVER AND USE THEREOF | 2017-11-16 |
20170326257 | SATIATION PEPTIDES FOR WEIGHT LOSS AND ALTERED TASTE SENSITIVITY | 2017-11-16 |
20170326258 | CONTRAST AGENTS BASED ON LONG-LIVED NUCLEAR SINGLET STATES AND RELATED METHODS | 2017-11-16 |
20170326259 | STABILIZED RADIOLABELED ANTI-CD45 IMMUNOGLOBULIN COMPOSITIONS | 2017-11-16 |
20170326260 | ANTIBODIES THAT BIND ACTIVATABLE ANTIBODIES AND METHODS OF USE THEREOF | 2017-11-16 |
20170326261 | BIFUNCTIONAL do2pa DERIVATIVES, CHELATES WITH METALLIC CATIONS AND USE THEREOF | 2017-11-16 |
20170326262 | ULTRAVIOLET AND MISTING DISINFECTING UNIT | 2017-11-16 |
20170326263 | SCENTED ATTACHMENT FOR CONTAINERS | 2017-11-16 |
20170326264 | COMPACT AIR CLEANER USING UV LED AND PHOTOCATALYTIC FILTER | 2017-11-16 |
20170326265 | APPARATUS AND METHOD FOR DETECTING MOISTURE IN A VACUUM CHAMBER | 2017-11-16 |
20170326266 | GLASS COMPOSITION FOR WOUND CARE, WOUND COVERING MATERIAL, AND METHOD FOR PRODUCING SAME | 2017-11-16 |
20170326267 | WOUND DRESSING | 2017-11-16 |
20170326268 | MEDICAL ADHESIVES FOR STOPPING HEAVY BLEEDING AND SEALING LEAKAGES | 2017-11-16 |
20170326269 | EMBOLISATION AGENT THAT CAN SEAL OFF VARICOSITY AND/OR HEMORRHOIDS | 2017-11-16 |
20170326270 | TISSUE SUBSTITUTE MATERIALS AND METHODS FOR TISSUE REPAIR | 2017-11-16 |
20170326271 | METHODS AND COMPOSITIONS FOR TREATING TENDON DEGENERATION | 2017-11-16 |
20170326272 | Deposition-Conversion Method For Tunable Calcium Phosphate Coatings On Substrates And Apparatus Prepared Thereof | 2017-11-16 |
20170326273 | Human Airway Stem Cells in Lung Epithelial Engineering | 2017-11-16 |
20170326274 | BIO-RESORBABLE RETICULAR PROSTHESIS AND RELATED MANUFACTURING METHOD | 2017-11-16 |
20170326275 | Chitosan Hydrogel Microbead | 2017-11-16 |
20170326276 | MESH IMPLANT FOR USE IN RECONSTRUCTION OF SOFT TISSUE DEFECTS | 2017-11-16 |
20170326277 | PORTABLE NEGATIVE-PRESSURE DEVICE | 2017-11-16 |
20170326278 | SEQUENTIAL PROCESSING OF BIOLOGICAL FLUIDS | 2017-11-16 |
20170326279 | BREAST PUMP SYSTEM | 2017-11-16 |
20170326280 | IMPLANT CONNECTOR | 2017-11-16 |
20170326281 | VENTRICULAR CUFF | 2017-11-16 |
20170326282 | BLOOD TREATMENT SYSTEMS AND METHODS | 2017-11-16 |
20170326283 | SYSTEMS FOR LVAD OPERATION DURING COMMUNICATION LOSSES | 2017-11-16 |
20170326284 | Method for Controlling a Blood Treatment Device While Considering Patient Feedback in the Treatment of Blood and Blood Treatment Device | 2017-11-16 |
20170326285 | DIALYSIS SYSTEM AND METHODS | 2017-11-16 |
20170326286 | DIALYSIS SYSTEM INCLUDING WIRELESS PATIENT DATA | 2017-11-16 |
20170326287 | RENAL THERAPY SYSTEM INCLUDING A BLOOD PRESSURE MONITOR | 2017-11-16 |
20170326288 | MEDICAL RESERVOIR LEVEL SENSOR | 2017-11-16 |
20170326289 | AN ARRANGEMENT FOR CARDIOPULMONARY BYPASS, AND A METHOD FOR CARDIOPULMONARY BYPASS | 2017-11-16 |
20170326290 | MEDICAL APPARATUS PACKAGE | 2017-11-16 |
20170326291 | DRUG ADMINISTRATION MECHANISM, METHOD FOR USING DRUG ADMINISTRATION MECHANISM, AND PUMP UNIT FOR DRUG ADMINISTRATION MECHANISM | 2017-11-16 |
20170326292 | SPRING-DRIVEN DRUG DELIVERY DEVICE | 2017-11-16 |
20170326293 | Syringe Infusion Pump | 2017-11-16 |
20170326294 | CLAMPING DEVICE | 2017-11-16 |
20170326295 | PASSIVE RESTART Y-SITE | 2017-11-16 |
20170326296 | PREDICTED TIME TO ASSESS AND/OR CONTROL A GLYCEMIC STATE | 2017-11-16 |
20170326297 | BIOINJECTION DEVICE HAVING A TIP WITH A PLURALITY OF DIRECTIONAL DISPERSION APERTURES | 2017-11-16 |
20170326298 | Auto-Injector | 2017-11-16 |